Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based regimens for initial treatment of HIV infection: a systematic review and meta-analysis of randomised trials.

Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD.

Clin Infect Dis. 2016 Apr 18. pii: ciw236. [Epub ahead of print]

PMID:
27090986
2.

Is hand-grip another culprit for the risk of fractures in HIV-positive patients?

Postorino MC, Torti C, Carè I, Pisani V, Strazzulla A, Vaccaro V, Costa C, Provenzano F, Mazzitelli M, Pujia A, Montalcini T.

New Microbiol. 2016 Jan;39(1):61-4.

3.

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.

Fontana RJ, Brown RS Jr, Moreno-Zamora A, Prieto M, Joshi S, Londoño MC, Herzer K, Chacko KR, Stauber RE, Knop V, Jafri SM, Castells L, Ferenci P, Torti C, Durand CM, Loiacono L, Lionetti R, Bahirwani R, Weiland O, Mubarak A, ElSharkawy AM, Stadler B, Montalbano M, Berg C, Pellicelli AM, Stenmark S, Vekeman F, Ionescu-Ittu R, Emond B, Reddy KR.

Liver Transpl. 2016 Apr;22(4):446-58. doi: 10.1002/lt.24416.

PMID:
26890629
4.

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord.

J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465. Epub 2016 Jan 28.

PMID:
26825119
5.

Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.

Scaggiante R, Andreis S, Basso M, Franchin E, Franzetti M, Del Vecchio C, Torti C, Mengoli C, Cruciani M, Sarmati L, Palù G, Parisi SG.

J Med Virol. 2016 Jul;88(7):1211-21. doi: 10.1002/jmv.24441. Epub 2015 Dec 15.

PMID:
26636290
6.

Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV Cohort.

Postorino MC, Luciani F, Mangano C, Carpentieri MS, Scerbo P, Priamo A, Berardelli G, Marino R, Vallone A, Serrao N, Pisani V, Costa C, Terremoto A, Foti G, Cosco L, Calderazzo M, Corigliano D, Scordo P, Strazzulla A, Torti C; CalabrHIV Study Group.

Mediterr J Hematol Infect Dis. 2015 Oct 8;7(1):e2015054. doi: 10.4084/MJHID.2015.054. eCollection 2015.

7.

Virological Mechanisms in the Coinfection between HIV and HCV.

Liberto MC, Zicca E, Pavia G, Quirino A, Marascio N, Torti C, Focà A.

Mediators Inflamm. 2015;2015:320532. doi: 10.1155/2015/320532. Epub 2015 Oct 1. Review.

8.

Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).

Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, Mazzotta F, Gori A, Sighinolfi L, Pan A, Cauda R, Scalzini A, Quiros-Roldan E, Nasta P, Gregis G, Benatti S, Digiambenedetto S, Ladisa N, Giralda M, Saracino A, Castelnuovo F, Di Pietro M, Lo Caputo S, Lapadula G, Costarelli S, Lorenzotti S, Mazzini N, Paraninfo G, Casari S, Focà E, Pezzoli C, Fabbiani M, Monno L, Pierotti P, Ble C, Leone S, Postorino MC, Fornabaio C, Zacchi F, Zoncada A, Carosi G.

Int J Epidemiol. 2015 Oct 7. pii: dyv192. [Epub ahead of print] No abstract available.

PMID:
26445966
9.

Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implications.

Strazzulla A, Barreca GS, Giancotti A, Pisani V, Costa C, Zicca E, La Boria A, Roveda L, Liberto MC, Tucci L, Donato G, Focà A, Torti C.

Infez Med. 2015 Sep;23(3):224-9.

10.

Professional Acquisition of M. bovis in Calabria Region (Southern Italy): A Challenging Case of Osteomyelitis in a Migrant Patient from Bulgaria.

Quirino A, Torti C, Strazzulla A, Nisticò S, Galati L, Barreca GS, Lamberti AG, Berardelli G, Pacciarini M, Gasparini G, Pisani V, Gambardella A, Liberto MC, Focà A.

Case Rep Infect Dis. 2015;2015:794715. doi: 10.1155/2015/794715. Epub 2015 Jul 14.

11.

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors.

De Luca A, Di Giambenedetto S, Lo Presti A, Sierra S, Prosperi M, Cella E, Giovanetti M, Torti C, Caudai C, Vicenti I, Saladini F, Almi P, Grima P, Blanc P, Fabbiani M, Rossetti B, Gagliardini R, Kaiser R, Ciccozzi M, Zazzi M.

Open Forum Infect Dis. 2015 Mar 31;2(2):ofv043. doi: 10.1093/ofid/ofv043. eCollection 2015 Apr.

12.

The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.

Coppolino G, Simeoni M, Summaria C, Postorino MC, Rivoli L, Strazzulla A, Torti C, Fuiano G.

J Nephrol. 2015 Aug;28(4):393-402. doi: 10.1007/s40620-015-0214-0. Epub 2015 Jun 9. Review.

PMID:
26054819
13.

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.

Lapadula G, Chatenoud L, Gori A, Castelli F, Di Giambenedetto S, Fabbiani M, Maggiolo F, Focà E, Ladisa N, Sighinolfi L, Di Pietro M, Pan A, Torti C; Italian MASTER Cohort.

PLoS One. 2015 May 28;10(5):e0124741. doi: 10.1371/journal.pone.0124741. eCollection 2015.

14.

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.

Lapadula G, Costarelli S, Chatenoud L, Castelli F, Astuti N, Di Giambenedetto S, Quiros-Roldan E, Sighinolfi L, Ladisa N, Di Pietro M, Zoncada A, Di Filippo E, Gori A, Nasta P, Torti C; Italian MASTER Cohort.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):312-8. doi: 10.1097/QAI.0000000000000585.

PMID:
25723139
15.

Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.

Peta V, Torti C, Milic N, Focà A, Abenavoli L.

World J Hepatol. 2015 Jan 27;7(1):44-52. doi: 10.4254/wjh.v7.i1.44. Review.

16.

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.

Postorino MC, Prosperi M, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Saracino A, Costarelli S, Lorenzotti S, Sighinolfi L, Di Pietro M, Torti C; MASTER Study Group.

Clin Microbiol Infect. 2015 Apr;21(4):386.e1-9. doi: 10.1016/j.cmi.2014.10.022. Epub 2014 Nov 11.

17.

Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports.

Campione E, Diluvio L, Terrinoni A, Orlandi A, Latino MP, Torti C, Pietroleonardo L, Botti E, Chimenti S, Bianchi L.

BMC Res Notes. 2014 Dec 17;7:929. doi: 10.1186/1756-0500-7-929.

18.

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults.

Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

AIDS. 2015 Jan 14;29(2):193-200. doi: 10.1097/QAD.0000000000000530.

PMID:
25426810
19.

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.

New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.

20.

Challenging clinical cases in HCV infection.

Strazzulla A, Matera G, Mammone SV, Vaccaro V, Pisani V, Costa C, Manti F, Doldo P, Cosco L, Quintieri F, Cesario F, Liberto MC, Giancotti A, Torti C, Focà A.

BMC Infect Dis. 2014;14 Suppl 5:S7. doi: 10.1186/1471-2334-14-S5-S7. Epub 2014 Sep 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk